(Q39193013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author

Marie-Laure Arcangeli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Michel Aurrand-Lions

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Patrice Dubreuil

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Paulo De Sepulveda

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

A Chaix

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

S Lopez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

E Voisset

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Y Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M Vita

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

S Letard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

S Audebert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

P Finetti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

D Birnbaum

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

F Bertucci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

18 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

872-881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2013.12

24 February 2020

exact match

0 references

cites work

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Mastocytosis: pathology, genetics, and current options for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

KIT mutations are common in testicular seminomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Activating c-kit gene mutations in human germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Signal transduction by several KIT juxtamembrane domain mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

FES kinase participates in KIT-ligand induced chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

c-Kit-mediated overlapping and unique functional and biochemical outcomes via diverse signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Stat1 associates with c-kit and is activated in response to stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

The tyrosine kinase FES is an essential effector of KITD816V proliferation signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.12

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23416972%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference